Valuation: ALTEOGEN Inc.

Market Cap 21,133B 15.2B 13.04B 12.18B 11.17B 21.01B 1,453B 21.35B 144B 56.26B 729B 57.07B 55.83B 2,409B P/E 2026 *
71.3x
P/E 2027 * 52.7x
Enterprise Value 20.62B 14.83M 12.72M 11.88M 10.9M 20.5M 1.42B 20.84M 140M 54.9M 711M 55.7M 54.49M 2.35B EV / Sales 2026 *
42.9x
EV / Sales 2027 * 31.1x
Free-Float
57.13%
Yield 2026 *
0.16%
Yield 2027 * 0.14%
1 day+1.85%
1 week-7.33%
Current month+27.89%
1 month+42.69%
3 months+10.36%
6 months+3.29%
Current year-12.22%
1 week 288,000
Extreme 288000
326,500
1 month 198,076.92
Extreme 198076.923076
356,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 32,346.15
Extreme 32346.153846
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap.
5/21/25 A Fiscal year

Chief Executive Officer

7,200 0.0135%
3/27/24 A Sell 1,600,000 3.0182%
1/5/24 A Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+1.85%-7.33%-10.23%+793.66% 14.69B
+3.78%+5.37%+47.06%-0.42% 80.91B
+5.49%+20.35%-38.64%-38.47% 53.62B
+0.85%-4.04%-2.31%+30.25% 50.13B
+0.23%-3.71%+11.44%+170.56% 47.97B
+4.24%+6.08%+59.56%-16.41% 31.41B
+176.97%+173.88%+524.79%+56.99% 25.14B
+4.05%+6.38%+50.33%+98.01% 25.03B
+1.66%+2.83%-3.58%+212.40% 21.45B
+0.22%+5.48%+65.69%+127.79% 16.93B
Average +19.79%+2.37%+70.41%+143.43% 36.73B
Weighted average by Cap. +14.40%+2.77%+52.75%+79.92%

Financials

2026 *2027 *
Net sales 481B 346M 297M 277M 254M 478M 33.06B 486M 3.27B 1.28B 16.58B 1.3B 1.27B 54.82B 655B 471M 404M 377M 346M 651M 45.05B 662M 4.45B 1.74B 22.59B 1.77B 1.73B 74.7B
Net income 299B 215M 185M 172M 158M 297M 20.56B 302M 2.03B 796M 10.31B 808M 790M 34.09B 373B 269M 230M 215M 197M 371M 25.66B 377M 2.54B 994M 12.87B 1.01B 986M 42.56B
Net Debt -510B -367M -314M -294M -269M -507M -35.04B -515M -3.46B -1.36B -17.57B -1.38B -1.35B -58.1B -765B -550M -472M -441M -404M -760M -52.57B -773M -5.2B -2.04B -26.36B -2.06B -2.02B -87.17B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
19/08/26 303,500.00 +1.85% 360,184
18/08/26 ₩298,000.00 -5.10% 456,936
14/08/26 ₩314,000.00 -1.10% 375,775
13/08/26 ₩317,500.00 0.00% 664,330
12/08/26 ₩317,500.00 -3.05% 454,346
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
303,500.00KRW
Average target price
372,051.28KRW
Spread / Average Target
+22.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock